InTandem Capital Partners has hired Lazard to advise on a continuation vehicle (CV) for portfolio company Ivy Fertility, according to three sources familiar with the matter.
This news service reported in August that InTandem was considering a CV process for the San Diego-based reproductive services group, having previously retained Harris Williams at the start of this year to advise on a potential sale effort. The sponsor planned to bring Ivy Fertility to market in 2025 after gauging buyer interest, but never launched a formal sale process, as reported.
Related articles
Press ReleaseMay 8, 2026
West Enclave Merger Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 13, 2026
May 8, 2026
Press ReleaseMay 8, 2026
Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)
May 8, 2026
Press ReleaseMay 8, 2026
Con Edison Announces $2 Billion At-The-Market (ATM) Equity Offering Program
May 8, 2026
← Back to all articles
Generated by Yeal